Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

NCT06573151 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ruijin Hospital